Novo Nordisk A/S - share repurchase programme
==========

Novo Nordisk A/S has initiated a share repurchase programme in accordance with regulations. The programme, which began on May 6, 2024, is part of an overall share repurchase programme of up to DKK 20 billion to be executed over a 12-month period starting on February 6, 2024. Under the current programme, Novo Nordisk will repurchase B shares for an amount up to DKK 2.2 billion between May 7, 2024, and August 5, 2024. As of June 28, 2024, Novo Nordisk has repurchased a total of 10,061,625 B shares at an average share price of DKK 873.45 per B share, equal to a transaction value of DKK 8,788,370,170. Novo Nordisk currently owns a total of 11,427,189 B shares as treasury shares, corresponding to 0.3% of the share capital. The company expects to repurchase B shares for an amount up to DKK 20 billion during the 12-month period. Novo Nordisk is a global healthcare company founded in 1923 and headquartered in Denmark. It employs about 66,000 people in 80 countries and markets its products in around 170 countries.

#NovoNordisk #ShareRepurchase #Regulations #BShares #TreasuryShares #Healthcare

https://finance.yahoo.com/news/novo-nordisk-share-repurchase-programme-131900091.html